© 2003 Canadian Medical Association or its licensors tant functional gain, especially for
patients with cervical spinal cord injuries. Therefore, even the small improvement observed …

Background: A systematic review of the evidence pertaining to methylprednisolone infusion
following acute spinal cord injury was conducted in order to address the persistent confusion …

Overview: The National Acute Spinal Cord Injury Studies (NASCIS II and III) and the
Cochrane review advocate the administration of high dose methylprednisolone following …

Object. Since publication in 1990, results from the National Acute Spinal Cord Injury Study II
(NASCIS II) trial have changed the way patients suffering an acute spinal cord injury (SCI) …

BACKGROUND CONTEXT: Methylprednisolone has evolved during the 1990s, through the
results obtained from the National Acute Spinal Cord Injury Studies NASCIS II and III, as a …

From the beginning, the reporting of the results of National Acute Spinal Cord Injury Studies
(NASCIS) II and III has been incomplete, leaving clinicians in the spinal cord injury (SCI) …

Methylprednisolone has become widely used in the management of acute spinal cord injury
and is considered by many to represent a “standard of care.” This is largely based on the …

Study design: Systematic literature review for primary data using predefined inclusion,
exclusion and validity criteria. Primary outcome measure was standardised neurological …

Objective: To determine the practice patterns for methylprednisolone administration for
patients with acute spinal cord injury (SCI) within the spinal surgery community across …

Objective: To re-evaluate practice patterns for methylprednisolone (MP) administration in
patients with acute spinal cord injury (SCI) within the spinal surgery community across …